Use of imidazoquinolinamines as adjuvants in DNA vaccination
Номер патента: NZ524792A
Опубликовано: 24-09-2004
Автор(ы): John Philip Tite, Lindy Louise Thomsen, Peter Topley
Принадлежит: Glaxo Group Ltd
Опубликовано: 24-09-2004
Автор(ы): John Philip Tite, Lindy Louise Thomsen, Peter Topley
Принадлежит: Glaxo Group Ltd
Реферат: Disclosed herein is a vaccine composition and use of a 1H-imidazo[4,5-c]-4-amine derivative as an adjuvant for use with nucleic acid vaccination, wherein a vaccine composition comprises (i) an adjuvant component comprising a 1H-imidazo[4,5-c]quinolin-4-amine derivative and (ii) an immunogen component comprising a nucleotide sequence encoding an antigenic peptide or protein associated with a disease state, wherein the adjuvant component enhances the immune responses in a mammal to the antigenic peptide or protein.
Use of imidazopyrimidine for modulating human immune response
Номер патента: EP3710007A1. Автор: Ofer Levy,David A. Scott,Frederic Feru,David J. Dowling,Francesco Borriello,Spencer E. Brightman. Владелец: Dana Farber Cancer Institute Inc. Дата публикации: 2020-09-23.